Cargando…

Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report

BACKGROUND: Toxic epidermal necrolysis (TEN) is a rare life-threatening condition almost exclusively attributed to drugs. The main etiologic factors for TEN are sulphonamides, anticonvulsants, and antibiotics; however, there are no published reports of warfarin causing TEN. CASE PRESENTATION: We pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasahara, Katsuaki, Gotoh, Yoshimitsu, Kuroyanagi, Yoshiyuki, Nagano, China
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512990/
https://www.ncbi.nlm.nih.gov/pubmed/28709416
http://dx.doi.org/10.1186/s12882-017-0648-9
_version_ 1783250570317922304
author Kasahara, Katsuaki
Gotoh, Yoshimitsu
Kuroyanagi, Yoshiyuki
Nagano, China
author_facet Kasahara, Katsuaki
Gotoh, Yoshimitsu
Kuroyanagi, Yoshiyuki
Nagano, China
author_sort Kasahara, Katsuaki
collection PubMed
description BACKGROUND: Toxic epidermal necrolysis (TEN) is a rare life-threatening condition almost exclusively attributed to drugs. The main etiologic factors for TEN are sulphonamides, anticonvulsants, and antibiotics; however, there are no published reports of warfarin causing TEN. CASE PRESENTATION: We present the case of a 3-year-old patient who developed TEN while receiving treatment for Henoch–Schönlein purpura nephritis (HSPN). With multiple-drug therapy comprising prednisolone, mizoribine, dipyridamole, and warfarin, it is difficult to detect which drug is the causative agent. While in most cases, diagnosis of the causative drug is based on clinical history without a lymphocyte transformation test (LTT), we performed the test three times and identified the causative drug as warfarin at the late phase. We continued HSPN treatment without warfarin, and results showed good renal function without life-threatening complications. CONCLUSION: To our knowledge, this is the first report about TEN caused by warfarin. Repeated LTTs could be useful for identifying TEN-causative drugs even in the late phase.
format Online
Article
Text
id pubmed-5512990
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55129902017-07-19 Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report Kasahara, Katsuaki Gotoh, Yoshimitsu Kuroyanagi, Yoshiyuki Nagano, China BMC Nephrol Case Report BACKGROUND: Toxic epidermal necrolysis (TEN) is a rare life-threatening condition almost exclusively attributed to drugs. The main etiologic factors for TEN are sulphonamides, anticonvulsants, and antibiotics; however, there are no published reports of warfarin causing TEN. CASE PRESENTATION: We present the case of a 3-year-old patient who developed TEN while receiving treatment for Henoch–Schönlein purpura nephritis (HSPN). With multiple-drug therapy comprising prednisolone, mizoribine, dipyridamole, and warfarin, it is difficult to detect which drug is the causative agent. While in most cases, diagnosis of the causative drug is based on clinical history without a lymphocyte transformation test (LTT), we performed the test three times and identified the causative drug as warfarin at the late phase. We continued HSPN treatment without warfarin, and results showed good renal function without life-threatening complications. CONCLUSION: To our knowledge, this is the first report about TEN caused by warfarin. Repeated LTTs could be useful for identifying TEN-causative drugs even in the late phase. BioMed Central 2017-07-14 /pmc/articles/PMC5512990/ /pubmed/28709416 http://dx.doi.org/10.1186/s12882-017-0648-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Kasahara, Katsuaki
Gotoh, Yoshimitsu
Kuroyanagi, Yoshiyuki
Nagano, China
Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
title Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
title_full Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
title_fullStr Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
title_full_unstemmed Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
title_short Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
title_sort warfarin-induced toxic epidermal necrolysis in combination therapy of henoch-schönlein purpura nephritis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512990/
https://www.ncbi.nlm.nih.gov/pubmed/28709416
http://dx.doi.org/10.1186/s12882-017-0648-9
work_keys_str_mv AT kasaharakatsuaki warfarininducedtoxicepidermalnecrolysisincombinationtherapyofhenochschonleinpurpuranephritisacasereport
AT gotohyoshimitsu warfarininducedtoxicepidermalnecrolysisincombinationtherapyofhenochschonleinpurpuranephritisacasereport
AT kuroyanagiyoshiyuki warfarininducedtoxicepidermalnecrolysisincombinationtherapyofhenochschonleinpurpuranephritisacasereport
AT naganochina warfarininducedtoxicepidermalnecrolysisincombinationtherapyofhenochschonleinpurpuranephritisacasereport